Trius Therapeutics Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$115.5M

338 transactions

Summary

Trius Therapeutics Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $54.4MSales: $1.7M43 insiders

Date	Insider	Type	Value
2013-09-11	THOMPSON JOHN CRAIG(Chief Commercial Officer)	D	$1.4M
2013-09-11	THOMPSON JOHN CRAIG(Chief Commercial Officer)	D	$921K
2013-09-11	THOMPSON JOHN CRAIG(Chief Commercial Officer)	D	$783K
2013-09-11	Fischer Seth H.Z.	D	$210K
2013-09-11	Schroeder Theodore R	D	$120K
2013-09-11	Kjellson Nina S	D	$120K
2013-09-11	ATWOOD BRIAN G	D	$120K
2013-09-11	Kjellson Nina S	D	$114K
2013-09-11	ATWOOD BRIAN G	D	$114K
2013-09-11	Schroeder Theodore R	D	$101K
2013-09-11	Kjellson Nina S	D	$101K
2013-09-11	ATWOOD BRIAN G	D	$101K
2013-09-11	Schroeder Theodore R	D	$90K
2013-09-11	Schroeder Theodore R	D	$86K
2013-09-11	Kjellson Nina S	D	$86K
2013-09-11	ATWOOD BRIAN G	D	$86K
2013-09-11	Schroeder Theodore R	D	$63K
2013-09-11	Kjellson Nina S	D	$63K
2013-09-11	ATWOOD BRIAN G	D	$63K
2013-09-11	THOMPSON JOHN CRAIG(Chief Commercial Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Trius Therapeutics Inc — Contributions, Lobbying & Contracts | Poliscope